Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
Breast Cancer: Targets and Therapy
Volume 15, 2023 - Issue
REVIEW
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review
, , 
, &
Xuemin Zhang1 Department of Emergency, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China;3 Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, People’s Republic of Chinahttps://orcid.org/0000-0002-2473-5883View further author information
https://orcid.org/0000-0002-2473-5883View further author information, &